Ready to write your
first Qlosi prescription?
to get your patients started
How to prescribe Qlosi1
as with all miotics
for 7 days to establish neuroadaptation
Not actual size
Who’s the right patient?

→ Dr. Brian Brightman, OD Lincoln, NE
Strong candidates include1:

→ Dr. Kevin Gee, OD Missouri City, TX
The Clear Start Kit
Qlosi patients to establish neuroadaptation
and to set up long-term adherence
BlinkRx Pharmacy
30-vial supply:
$79
60-vial supply:
$158 $99
recommended as first order
$119 per month after first fill
Samples & Starter Kits
and in-office conversations about Qlosi.
Not actual size
The Qlo Down
The Qlo Down is content featuring real ECPs, like you.
They’re talking about experiences with Qlosi: busting myths, chatting about patients it’s helped most, and sharing successes they’ve seen firsthand.
Watch more →
See the struggle,
spark the solution
Indication and Usage
Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4%, for topical ophthalmic use is a cholinergic receptor agonist indicated for the treatment of presbyopia in adults.
Important Safety Information
Contraindications
Hypersensitivity
Warnings and Precautions
Advise patients to not drive or operate machinery if vision is not clear (e.g., blurred vision). Exercise caution in night driving and other hazardous occupations in poor illumination.
Rare cases of retinal detachment have been reported with miotics. Examination of the retina is advised in all patients prior to initiation of therapy. Advise patients to seek immediate medical care with sudden onset of flashes of lights, floaters, or vision loss.
Qlosi is not recommended to be used when iritis is present.
Qlosi should not be administered while wearing contact lenses. Remove lenses prior to the instillation of Qlosi and wait 10 minutes before reinsertion.
Avoid touching the tip of the vial to the eye or any other surface.
Adverse Reactions
The most common adverse reactions (5% to 8%) are instillation site pain and headaches.
Please see full Prescribing Information here: qlosiecp.com/prescribing-information
References
- Qlosi [package insert]. Ponte Vedra, FL. Orasis Pharmaceuticals.
- Holland E, Karpecki P, Fingeret M, et al. Efficacy and safety of CSF-1 (0.4% pilocarpine hydrochloride) in presbyopia: pooled results of the NEAR phase 3 randomized, clinical trials. Clin Ther. 2024;46(2):104-113. doi:10.1016/j.clinthera.2023.12.005